Glass House Brands (GLAS) Change in Acquisitions & Divestments (2023 - 2026)
Glass House Brands (GLAS) posted quarterly Change in Acquisitions & Divestments of $800000.0 for Q1 2026, up 299725.47% quarter-over-quarter from -$267.0 in Q4 2023.
Glass House Brands (GLAS) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $800000.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.78 Bn | 42.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.97 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.74 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.53 Bn | 22.73 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Glass House Brands | 834.17 Mn | 815.61 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2023 | -267.00 |
| Dec 31, 2023 | -267.00 |